Dissecting the integrated mechanisms of protein turnover to prevent proteostatic decline with aging
剖析蛋白质周转的综合机制,以防止蛋白质沉积随衰老而下降
基本信息
- 批准号:10390925
- 负责人:
- 金额:$ 66.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-30 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdultAgeAgingAstrocytesBrainCell NucleusCell ProliferationCellsConflict (Psychology)ConfusionConsensusDNADataDeteriorationDeuterium OxideDiseaseElderlyEstradiolFRAP1 geneGoalsHeterogeneityIndividualIsotope LabelingIsotopesLabelLongevityMaintenanceMass Spectrum AnalysisMeasurementMethodologyMethodsMitoticMusMuscle CellsNeuronsPathway interactionsProtein BiosynthesisProteinsProteomicsQuality ControlResearchSirolimusSkeletal MuscleTestingTherapeuticTimeTissue SampleTissuesage relatedagedbasecell typeimprovedin vivomTOR inhibitionmouse modelnovelnovel strategiespreventprotein degradationproteostasissatellite cellstable isotope
项目摘要
SUMMARY
Proteostatic mechanisms fail with advancing age, resulting in the accumulation of damaged and dysfunctional
proteins. Protein breakdown and replacement with newly synthesized proteins (protein turnover) is the primary
mechanism to mitigate accumulation of damaged proteins over time. There are several conflicting findings
related to protein turnover, aging, and treatments that slow aging, which leave the field with fundamental
contradictions regarding protein turnover as a proteostatic mechanism. The current project seeks to
understand the fundamental mechanisms that regulate proteostatic maintenance so that we can
overcome a barrier to targeting this pillar of aging to slow age-related decline. Our studies indicate that:
1) aging does not universally decrease protein turnover, and in fact it increases the turnover of many proteins,
2) aging deceases the number of proteins that turnover (for which we introduce the term dynamic pool size), 3)
treatments that extend lifespan have nearly an equal number of proteins that increase and decrease protein
synthesis, which contradicts the notion that treatments that extend lifespan slow protein synthesis, and 4) some
treatments that increase lifespan decrease cell proliferation, which by itself decreases protein turnover in a non-
determinant manner. To date, these studies have been limited to tissue samples, which has restricted the
understanding of how individual cell types within a tissue influence overall tissue proteostasis. To overcome
these unknowns, the proposed studies use mouse models that allow cell-specific isolation of proteins and nuclei
in skeletal muscle and brain. The project will use both discovery-based and targeted proteomics with novel
deuterium oxide (D2O) labeling to examine cell-type-specific individual protein turnover and cell replication.
Through loss of proteostatic maintenance (aging) and gain of proteostatic maintenance (treatments that slow
aging), we will address the following specific aims: to determine cell-type specific proteins susceptible to
proteostatic decline with aging, to determine how a treatment that inhibits mTOR improves proteostasis, and to
determine how a treatment that does not directly inhibit mTOR improves proteostasis. The hypotheses are that:
the loss of proteostasis with aging results from cell-type specific changes in individual protein turnover rates and
decreases in the dynamic protein pool size, that inhibiting mTOR improves proteostatic maintenance by
decreasing cell proliferation while increasing turnover and dynamic pool size of proteins that are susceptible to
proteostatic decline, and that a lifespan-extending treatment that does not directly inhibit mTOR improves
proteostatic maintenance by mechanisms that do not include slowed cell proliferation. Progress toward targeting
age-related proteostatic deterioration has been hindered by contradictory and paradoxical results from protein
turnover studies. We expect that our approaches will narrow the scope of proteins susceptible to proteostatic
decline, and more importantly, will make significant advancements toward strategies to target these proteins to
maintain proteostasis with age.
摘要
随着年龄的增长,前列腺癌的机制失效,导致损伤和功能障碍的积累。
蛋白质。蛋白质的分解和被新合成的蛋白质替代(蛋白质周转)是主要的
减少受损蛋白质随时间积累的机制。有几个相互矛盾的发现
与蛋白质周转、衰老和延缓衰老的治疗有关,这给该领域留下了根本的
关于蛋白质周转作为蛋白质抑制机制的矛盾。目前的项目寻求
了解调节蛋白平衡维持的基本机制,以便我们能够
克服障碍,瞄准这一老龄化支柱,减缓与年龄相关的下降。我们的研究表明:
1)衰老并不普遍降低蛋白质的周转率,事实上它增加了许多蛋白质的周转率,
2)老化减少了周转的蛋白质数量(为此,我们引入了术语动态池大小),3)
延长寿命的治疗方法含有几乎相同数量的增加和减少蛋白质的蛋白质
合成,这与延长寿命的治疗方法减缓蛋白质合成的概念相矛盾,以及4)一些
延长寿命的治疗方法会减少细胞增殖,而细胞增殖本身就会降低非
决定性的态度。到目前为止,这些研究仅限于组织样本,这限制了
了解组织中的单个细胞类型如何影响整个组织的蛋白质平衡。要克服
对于这些未知因素,拟议中的研究使用了允许特定细胞分离蛋白质和细胞核的小鼠模型
在骨骼肌和大脑中。该项目将使用基于发现的蛋白质组学和靶向蛋白质组学
氧化氢(D2O)标记以检测特定细胞类型的个体蛋白质周转和细胞复制。
通过蛋白质维持的丧失(老化)和蛋白质维持的增加(减慢的治疗
,我们将解决以下具体目标:确定易感细胞类型的特定蛋白
蛋白质稳定性随着年龄的增长而下降,以确定抑制mTOR的治疗如何改善蛋白质稳定性,并
确定不直接抑制mTOR的治疗如何改善蛋白稳定性。假设是这样的:
随着年龄的增长,蛋白质稳定性的丧失是由于个体蛋白质周转率和细胞类型的特定变化造成的。
减少动态蛋白质池大小,抑制mTOR通过以下方式改善蛋白质静态维持
减少细胞增殖,同时增加易感蛋白质的周转率和动态池大小
蛋白抑制剂下降,而不直接抑制mTOR的延长寿命的治疗改善了
通过不包括减慢细胞增殖的机制来维持蛋白质的稳定。在目标方面的进展
与年龄相关的蛋白降解酶的恶化受到来自蛋白质的矛盾和矛盾的结果的阻碍
离职率研究。我们预计,我们的方法将缩小易受蛋白质抑制剂影响的蛋白质的范围。
下降,更重要的是,将在靶向这些蛋白质的策略方面取得重大进展
随着年龄的增长保持蛋白质平衡。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Benjamin Francis Miller其他文献
Benjamin Francis Miller的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Benjamin Francis Miller', 18)}}的其他基金
Mechanism through which chronically elevated mTOR activity impairs aged muscle recovery after disuse atrophy
长期升高的 mTOR 活性损害废用性萎缩后老年肌肉恢复的机制
- 批准号:
10641855 - 财政年份:2022
- 资助金额:
$ 66.01万 - 项目类别:
Mechanism through which chronically elevated mTOR activity impairs aged muscle recovery after disuse atrophy
长期升高的 mTOR 活性损害废用性萎缩后老年肌肉恢复的机制
- 批准号:
10473096 - 财政年份:2022
- 资助金额:
$ 66.01万 - 项目类别:
Determining the context specificity of metformin treatment on muscle mitochondria and healthspan
确定二甲双胍治疗对肌肉线粒体和健康寿命的背景特异性
- 批准号:
10462944 - 财政年份:2022
- 资助金额:
$ 66.01万 - 项目类别:
Dissecting the integrated mechanisms of protein turnover to prevent proteostatic decline with aging
剖析蛋白质周转的综合机制,以防止蛋白质沉积随衰老而下降
- 批准号:
10706458 - 财政年份:2022
- 资助金额:
$ 66.01万 - 项目类别:
Determining the context specificity of metformin treatment on muscle mitochondria and healthspan
确定二甲双胍治疗对肌肉线粒体和健康寿命的背景特异性
- 批准号:
10596174 - 财政年份:2022
- 资助金额:
$ 66.01万 - 项目类别:
DNA turnover in myofibers is an unrecognized mechanism for maintaining skeletal muscle health
肌纤维中的 DNA 更新是维持骨骼肌健康的一种未被认识的机制
- 批准号:
10239252 - 财政年份:2020
- 资助金额:
$ 66.01万 - 项目类别:
A novel approach to understand a mechanism of proteostatic decline with aging
一种理解衰老过程中蛋白质抑制下降机制的新方法
- 批准号:
10229298 - 财政年份:2020
- 资助金额:
$ 66.01万 - 项目类别:
DNA turnover in myofibers is an unrecognized mechanism for maintaining skeletal muscle health
肌纤维中的 DNA 更新是维持骨骼肌健康的一种未被认识的机制
- 批准号:
10065144 - 财政年份:2020
- 资助金额:
$ 66.01万 - 项目类别:
Does insulin sensitivity impact the potential of metformin to slow aging?
胰岛素敏感性是否会影响二甲双胍延缓衰老的潜力?
- 批准号:
10579890 - 财政年份:2019
- 资助金额:
$ 66.01万 - 项目类别:
Does insulin sensitivity impact the potential of metformin to slow aging?
胰岛素敏感性是否会影响二甲双胍延缓衰老的潜力?
- 批准号:
9999395 - 财政年份:2019
- 资助金额:
$ 66.01万 - 项目类别:
相似海外基金
Developing a Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening among Rural Screening Age-Eligible Adults
制定年轻人介导的干预措施,以增加农村符合筛查年龄的成年人的结直肠癌筛查
- 批准号:
10653464 - 财政年份:2023
- 资助金额:
$ 66.01万 - 项目类别:
Doctoral Dissertation Research: Estimating adult age-at-death from the pelvis
博士论文研究:从骨盆估算成人死亡年龄
- 批准号:
2316108 - 财政年份:2023
- 资助金额:
$ 66.01万 - 项目类别:
Standard Grant
Determining age dependent factors driving COVID-19 disease severity using experimental human paediatric and adult models of SARS-CoV-2 infection
使用 SARS-CoV-2 感染的实验性人类儿童和成人模型确定导致 COVID-19 疾病严重程度的年龄依赖因素
- 批准号:
BB/V006738/1 - 财政年份:2020
- 资助金额:
$ 66.01万 - 项目类别:
Research Grant
Transplantation of Adult, Tissue-Specific RPE Stem Cells for Non-exudative Age-related macular degeneration (AMD)
成人组织特异性 RPE 干细胞移植治疗非渗出性年龄相关性黄斑变性 (AMD)
- 批准号:
10294664 - 财政年份:2020
- 资助金额:
$ 66.01万 - 项目类别:
Sex differences in the effect of age on episodic memory-related brain function across the adult lifespan
年龄对成人一生中情景记忆相关脑功能影响的性别差异
- 批准号:
422882 - 财政年份:2019
- 资助金额:
$ 66.01万 - 项目类别:
Operating Grants
Modelling Age- and Sex-related Changes in Gait Coordination Strategies in a Healthy Adult Population Using Principal Component Analysis
使用主成分分析对健康成年人群步态协调策略中与年龄和性别相关的变化进行建模
- 批准号:
430871 - 财政年份:2019
- 资助金额:
$ 66.01万 - 项目类别:
Studentship Programs
Transplantation of Adult, Tissue-Specific RPE Stem Cells as Therapy for Non-exudative Age-Related Macular Degeneration AMD
成人组织特异性 RPE 干细胞移植治疗非渗出性年龄相关性黄斑变性 AMD
- 批准号:
9811094 - 财政年份:2019
- 资助金额:
$ 66.01万 - 项目类别:
Study of pathogenic mechanism of age-dependent chromosome translocation in adult acute lymphoblastic leukemia
成人急性淋巴细胞白血病年龄依赖性染色体易位发病机制研究
- 批准号:
18K16103 - 财政年份:2018
- 资助金额:
$ 66.01万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Doctoral Dissertation Research: Literacy Effects on Language Acquisition and Sentence Processing in Adult L1 and School-Age Heritage Speakers of Spanish
博士论文研究:识字对西班牙语成人母语和学龄传统使用者语言习得和句子处理的影响
- 批准号:
1823881 - 财政年份:2018
- 资助金额:
$ 66.01万 - 项目类别:
Standard Grant
Adult Age-differences in Auditory Selective Attention: The Interplay of Norepinephrine and Rhythmic Neural Activity
成人听觉选择性注意的年龄差异:去甲肾上腺素与节律神经活动的相互作用
- 批准号:
369385245 - 财政年份:2017
- 资助金额:
$ 66.01万 - 项目类别:
Research Grants